| Members |
acceptabilityId |
| 4A2 |
Acceptable (foundation metadata concept) |
| 4B |
Acceptable (foundation metadata concept) |
| 4C |
Acceptable (foundation metadata concept) |
| 4D (four dimensional) ultrasonography |
Acceptable (foundation metadata concept) |
| 4D (four dimensional) ultrasound |
Acceptable (foundation metadata concept) |
| 4D (four dimensional) ultrasound scan |
Acceptable (foundation metadata concept) |
| 4Fr |
Acceptable (foundation metadata concept) |
| 4H leucodystrophy |
Preferred (foundation metadata concept) |
| 4H leukodystrophy (disorder) |
Preferred (foundation metadata concept) |
| 4H post incubation |
Acceptable (foundation metadata concept) |
| 4H post peritoneal dialysis |
Acceptable (foundation metadata concept) |
| 4H specimen |
Acceptable (foundation metadata concept) |
| 4H specimen |
Acceptable (foundation metadata concept) |
| 4H syndrome |
Acceptable (foundation metadata concept) |
| 4KB5 |
Acceptable (foundation metadata concept) |
| 4a |
Preferred (foundation metadata concept) |
| 4a-hydroxytetrahydrobiopterin dehydratase |
Preferred (foundation metadata concept) |
| 4a-hydroxytetrahydrobiopterin dehydratase (substance) |
Preferred (foundation metadata concept) |
| 4ab |
Preferred (foundation metadata concept) |
| 4b |
Preferred (foundation metadata concept) |
| 4c |
Preferred (foundation metadata concept) |
| 4d |
Preferred (foundation metadata concept) |
| 4e |
Preferred (foundation metadata concept) |
| 4f |
Preferred (foundation metadata concept) |
| 4p minus syndrome |
Acceptable (foundation metadata concept) |
| 4p partial monosomy syndrome |
Preferred (foundation metadata concept) |
| 4p partial monosomy syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4p partial trisomy syndrome |
Preferred (foundation metadata concept) |
| 4p partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4p16.3 microduplication syndrome |
Preferred (foundation metadata concept) |
| 4p16.3 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4q partial monosomy syndrome |
Preferred (foundation metadata concept) |
| 4q partial monosomy syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4q partial trisomy syndrome |
Preferred (foundation metadata concept) |
| 4q partial trisomy syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4q21 microdeletion syndrome |
Preferred (foundation metadata concept) |
| 4q21 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4q25 proximal deletion syndrome |
Preferred (foundation metadata concept) |
| 4q25 proximal deletion syndrome (disorder) |
Preferred (foundation metadata concept) |
| 4th |
Acceptable (foundation metadata concept) |
| 4th floor |
Acceptable (foundation metadata concept) |
| 4th generation HIV ELISA |
Acceptable (foundation metadata concept) |
| 4th left lumbar vein |
Acceptable (foundation metadata concept) |
| 4th nerve palsy |
Acceptable (foundation metadata concept) |
| 4th right lumbar vein |
Acceptable (foundation metadata concept) |
| 4x/wk |
Acceptable (foundation metadata concept) |
| 5 |
Preferred (foundation metadata concept) |
| 5 |
Preferred (foundation metadata concept) |
| 5 (qualifier value) |
Preferred (foundation metadata concept) |
| 5 French gauge |
Preferred (foundation metadata concept) |
| 5 French gauge (qualifier value) |
Preferred (foundation metadata concept) |
| 5 IU/0.1mL |
Acceptable (foundation metadata concept) |
| 5 International Units in 0.1mL |
Preferred (foundation metadata concept) |
| 5 International Units in 0.1mL (qualifier value) |
Preferred (foundation metadata concept) |
| 5 alpha-cholest-8(9)-en-3 beta-ol |
Acceptable (foundation metadata concept) |
| 5 aza 2 desoxycytidine |
Acceptable (foundation metadata concept) |
| 5 azacytidine |
Acceptable (foundation metadata concept) |
| 5 azadeoxycytidine |
Acceptable (foundation metadata concept) |
| 5 hours |
Preferred (foundation metadata concept) |
| 5 hours (qualifier value) |
Preferred (foundation metadata concept) |
| 5 level of presenting part in relation to ischial spines |
Preferred (foundation metadata concept) |
| 5 level of presenting part in relation to ischial spines (finding) |
Preferred (foundation metadata concept) |
| 5 o'clock position |
Preferred (foundation metadata concept) |
| 5 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
| 5 o'clock position on mammogram |
Preferred (foundation metadata concept) |
| 5 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
| 5 times a week |
Acceptable (foundation metadata concept) |
| 5% Acetic acid |
Preferred (foundation metadata concept) |
| 5% Acetic acid (substance) |
Preferred (foundation metadata concept) |
| 5' Nucleotidase measurement |
Preferred (foundation metadata concept) |
| 5' Nucleotidase measurement (procedure) |
Preferred (foundation metadata concept) |
| 5' acylphosphoadenosine hydrolase |
Preferred (foundation metadata concept) |
| 5' acylphosphoadenosine hydrolase (substance) |
Preferred (foundation metadata concept) |
| 5'-exonuclease |
Acceptable (foundation metadata concept) |
| 5'-methylthioadenosine phosphorylase |
Preferred (foundation metadata concept) |
| 5'-methylthioadenosine phosphorylase (substance) |
Preferred (foundation metadata concept) |
| 5'-nucleotidase |
Preferred (foundation metadata concept) |
| 5'-nucleotidase (substance) |
Preferred (foundation metadata concept) |
| 5'-polynucleotidase |
Acceptable (foundation metadata concept) |
| 5,10-Methylenetetrahydrofolate reductase (FADH>2<) measurement |
Preferred (foundation metadata concept) |
| 5,10-Methylenetetrahydrofolate reductase (reduced flavin adenine dinucleotide) measurement |
Acceptable (foundation metadata concept) |
| 5,10-Methylenetetrahydrofolate reductase (reduced flavin adenine dinucleotide) measurement (procedure) |
Preferred (foundation metadata concept) |
| 5,10-Methylenetetrahydrofolate reductase deficiency |
Preferred (foundation metadata concept) |
| 5,10-Methylenetetrahydrofolate reductase deficiency (disorder) |
Preferred (foundation metadata concept) |
| 5,10-methenyltetrahydrofolate synthetase |
Acceptable (foundation metadata concept) |
| 5,10-methylenetetrahydrofolate reductase (FADH>2<) |
Preferred (foundation metadata concept) |
| 5,10-methylenetetrahydrofolate reductase (reduced flavin adenine dinucleotide) |
Acceptable (foundation metadata concept) |
| 5,10-methylenetetrahydrofolate reductase (reduced flavin adenine dinucleotide) (substance) |
Preferred (foundation metadata concept) |
| 5,10-methylenetetrahydrofolate reductase gene analysis |
Preferred (foundation metadata concept) |
| 5,10-methylenetetrahydrofolate reductase gene analysis (procedure) |
Preferred (foundation metadata concept) |
| 5,25-dihydroxy cholecalciferol |
Preferred (foundation metadata concept) |
| 5,25-dihydroxy cholecalciferol (substance) |
Preferred (foundation metadata concept) |
| 5,6-dihydrouracil |
Preferred (foundation metadata concept) |
| 5,6-dihydrouracil (substance) |
Preferred (foundation metadata concept) |
| 5,8,11,14-eicosatetraenoic acid |
Acceptable (foundation metadata concept) |
| 5,8,11-eicosatrienoic acid |
Preferred (foundation metadata concept) |
| 5,8,11-eicosatrienoic acid (substance) |
Preferred (foundation metadata concept) |
| 5-(3,4-diacetoxybut-1-ynyl)-2,2'-bithiophene deacetylase |
Preferred (foundation metadata concept) |
| 5-(3,4-diacetoxybut-1-ynyl)-2,2'-bithiophene deacetylase (substance) |
Preferred (foundation metadata concept) |
| 5-ASA |
Acceptable (foundation metadata concept) |
| 5-Aminolaevulinate synthase |
Preferred (foundation metadata concept) |
FHIR